Prescribing overview
Albon suspension targets susceptible bacterial infections; canine coccidiosis-associated bacterial enteritis is specifically labeled.
Key prescribing checks
- Confirm the organism and disease being treated. The label does not support using this antibiotic for viral disease or assuming every case of diarrhea has the same cause.
- Maintain appropriate hydration and assess the animal’s water intake during treatment. Poor intake or dehydration can change the clinical management required.
- Review sulfonamide precautions and medication history. Lack of improvement should trigger reassessment of the diagnosis and antimicrobial choice rather than an automatic extension of treatment.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Dogs and cats
US FDA-approved AlbonSusceptible label-listed respiratory, genitourinary, enteric and soft-tissue bacterial infections
Coccidiosis-associated bacterial enteritis indication is canine; not effective against viral/rickettsial infections.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Bacteriostatic inhibition of bacterial folate synthesis through competition with para-aminobenzoic acid.
Absorption, distribution, metabolism and elimination
In dogs, high protein binding and tubular reabsorption prolong exposure; drug is predominantly excreted unchanged. Do not assume identical feline metabolism.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Albon
Veterinary oral suspension; Dogs, Cats
Contraindications · when not to use
A formal contraindication list is not established in the reviewed source for this scope. This does not establish safety; confirm the exact product and full labeling.
Precautions & monitoring
- Label calls for usual sulfonamide precautions and adequate water intake; reassess if not improving.
The reviewed Albon suspension label provides no separate contraindication list; do not interpret this as absence of patient-specific restrictions.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Diarrhea occurred with massive canine overdoses; the label does not supply a comprehensive therapeutic-dose event table.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
| Species & indication | Labeled regimen | Eligibility & source |
|---|---|---|
| Dogs and catsLabel-listed susceptible bacterial infections; canine coccidiosis-associated enteritisAlbon oral suspension 5% (50 mg/mL) | Initial 55 mg/kg; subsequent doses 27.5 mg/kg Oral · Subsequent doses every 24 hours Usually 3–5 days; continue until asymptomatic for 48 hours, according to clinical response | Maintain adequate water intake; reassess diagnosis if no improvement within 2–3 days. Verify full dosing label ↗ |
This regimen is specific to the 5% dog/cat suspension, not livestock concentrates.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
A product-specific interaction summary has not been established here. An empty list must not be interpreted as “no interactions.” Review the full source and a species-appropriate clinical reference.
Monitoring
Monitor hydration, intake and infection response; observe usual sulfonamide precautions.
Client counseling
Follow the prescribed course and report worsening illness or poor water intake.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Store at 15–30°C.
Brands, formulations & ingredient identity
Active ingredients
Sulfadimethoxine
The uploaded Albon name maps to sulfadimethoxine, not to every sulfonamide or combination sulfonamide product.
This entry verifies the veterinary oral suspension. Other presentations, including livestock products, need their own species and concentration check before use.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Albon
- Formulation
- Veterinary oral suspension
- Label / product scope
- Dogs · Cats
Referenced dog/cat label; its coccidiosis-associated enteritis indication is canine.
Product label / source ↗References & review status
Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →